Literature DB >> 24122344

The possible effect of methylphenidate on kleptomania in a school-age girl with attention-deficit/hyperactivity disorder.

Savaş Yılmaz, Ayhan Bilgiç.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24122344     DOI： 10.1007/s00787-013-0484-9

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN： 1018-8827            Impact factor:   4.785


× No keyword cloud information.
  9 in total

1.  Bupropion XL for the sustained treatment of trichotillomania.

Authors:  Kimberly Gottlieb Klipstein; Lisa Berman
Journal:  J Clin Psychopharmacol       Date:  2012-04       Impact factor: 3.153

Review 2.  The neurobiology and genetics of impulse control disorders: relationships to drug addictions.

Authors:  Judson A Brewer; Marc N Potenza
Journal:  Biochem Pharmacol       Date:  2007-07-03       Impact factor: 5.858

3.  An adolescent with kleptomania and attention-deficit/hyperactivity disorder treated with methylphenidate.

Authors:  Sabri Hergüner; Canan Tanidir
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-08-08       Impact factor: 2.576

4.  Treatment for kleptomania.

Authors:  D J Feeney; W M Klykylo
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1997-06       Impact factor: 8.829

5.  Attentional bias and disinhibition toward gaming cues are related to problem gaming in male adolescents.

Authors:  Ruth J van Holst; Jeroen S Lemmens; Patti M Valkenburg; Jochen Peter; Dick J Veltman; Anna E Goudriaan
Journal:  J Adolesc Health       Date:  2011-09-03       Impact factor: 5.012

6.  Normative data on revised Conners Parent and Teacher Rating Scales.

Authors:  C H Goyette; C K Conners; R F Ulrich
Journal:  J Abnorm Child Psychol       Date:  1978-06

7.  Sustained-release bupropion versus naltrexone in the treatment of pathological gambling: a preliminary blind-rater study.

Authors:  Pinhas N Dannon; Katherine Lowengrub; Ernest Musin; Yehudit Gonopolski; Moshe Kotler
Journal:  J Clin Psychopharmacol       Date:  2005-12       Impact factor: 3.153

8.  A double-blind, placebo-controlled study of the opiate antagonist, naltrexone, in the treatment of kleptomania.

Authors:  Jon E Grant; Suck Won Kim; Brian L Odlaug
Journal:  Biol Psychiatry       Date:  2009-02-12       Impact factor: 13.382

9.  Psychopathology and comorbidity of psychiatric disorders in patients with kleptomania.

Authors:  Franck J Baylé; Hervé Caci; Bruno Millet; Sami Richa; Jean-Pierre Olié
Journal:  Am J Psychiatry       Date:  2003-08       Impact factor: 18.112
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.